The venture capital arm of Danske Bank A/S is buying eastern European drug companies to create a major competitor in a region where drug stocks are rising faster than the region's benchmark index. Amber Trust II, a fund jointly owned by Danske Bank and New York-based Firebird Management LLC, along with Citigroup Inc., the world's biggest bank by market value, and related funds purchased 34% of Lithuanian drugmaker AB Sanitas for $51.2 million earlier this year.
BBJ.hu (http://www.bbj.hu/main/news_14028_danske%2Bbank%2Bfund%2Bbuys%2Beastern%2Beuropean%2Bdrugmakers.html)